EFFECT OF SOME BENZYLHYDRAZINES AND BENZYLOXYAMINES ON DOPA AND 5-HYDROXYTRYPTOPHAN DECARBOXYLASE IN VIVO.
作者信息
HANSSON E, FLEMING R M, CLARK W G
出版信息
Int J Neuropharmacol. 1964 May;3:177-88. doi: 10.1016/0028-3908(64)90006-1.
PMID:14336525
Abstract
摘要
相似文献
1
EFFECT OF SOME BENZYLHYDRAZINES AND BENZYLOXYAMINES ON DOPA AND 5-HYDROXYTRYPTOPHAN DECARBOXYLASE IN VIVO.
Int J Neuropharmacol. 1964 May;3:177-88. doi: 10.1016/0028-3908(64)90006-1.
2
A SENSITIVE ASSAY FOR 5-HYDROXYTRYPTOPHAN DECARBOXYLASE.
Biochem Pharmacol. 1964 May;13:805-6. doi: 10.1016/0006-2952(64)90021-8.
3
5-HYDROXYTRYPTOPHAN DECARBOXYLASE IN RAT BRAIN: EFFECT OF HYPOTHALAMIC LESIONS.
Science. 1965 Feb 19;147(3660):887-8. doi: 10.1126/science.147.3660.887.
4
CEREBRAL METABOLISM OF DOPA-C14 IN RATS.
Int J Neuropharmacol. 1964 Apr;3:37-43. doi: 10.1016/0028-3908(64)90043-7.
5
MICRODETERMINATION OF MONOAMINE OXIDASE AND 5-HYDROXYTRYPTOPHAN DECARBOXYLASE ACTIVITIES IN NERVOUS TISSUES.
J Neurochem. 1965 Jan;12:15-23. doi: 10.1111/j.1471-4159.1965.tb10246.x.
6
[COMPARATIVE ACTION OF 2 DECARBOXYLASE INHIBITORS ON THE METABOLISM OF ENDOGENOUS AND EXOGENOUS 5-HYDROXYTRYPTAMINE].
Arch Int Pharmacodyn Ther. 1964 Jan 1;147:1-8.
7
INHIBITION OF CEREBRAL DECARBOXYLASE AND BEHAVIOUR.
Int J Neuropharmacol. 1964 Dec;3:550-64.
8
URINARY HISTAMINE EXCRETION IN THE GASTRECTOMISED RAT.
Life Sci (1962). 1965 Apr;4:787-95. doi: 10.1016/0024-3205(65)90311-5.
9
TRYPTOPHAN HYDROXYLATION IN CARCINOID TUMOURS.
Biochim Biophys Acta. 1964 Apr 4;86:176-9. doi: 10.1016/0304-4165(64)90173-4.
10
CHARACTERISTICS OF THE INHIBITION OF AROMATIC L-AMINO ACID DECARBOXYLASE BY ALPHA-METHYLAMINO ACIDS.
Arch Biochem Biophys. 1963 Oct;103:9-14. doi: 10.1016/0003-9861(63)90003-1.
引用本文的文献
1
Inhibition of tyrosine degradation in vivo by the dopa decarboxylase blocking agent NSD-1034.
Experientia. 1968 May 15;24(5):429-30. doi: 10.1007/BF02144368.
2
A pharmacological study of the adrenergic mechanisms involved in the stretch reflex of the decerebrate rat.
Br J Pharmacol. 1974 Mar;50(3):365-74. doi: 10.1111/j.1476-5381.1974.tb09611.x.
3
Brocresine in Parkinson's disease. Action of a peripheral and central decarboxylase inhibitor in potentiating levodopa.
J Neurol Neurosurg Psychiatry. 1973 Feb;36(1):27-9. doi: 10.1136/jnnp.36.1.27.
4
NSD 1034: an amino acid decarboxylase inhibitor with a stimulatory action on dopamine synthesis not mediated by classical dopamine receptors.
Naunyn Schmiedebergs Arch Pharmacol. 1988 Aug;338(2):148-61. doi: 10.1007/BF00174863.
5
Monoamine oxidase inhibitors antagonize the acceleration of brain dopamine synthesis induced by neuroleptic drugs in vivo: implications for the treatment of Tardive dyskinesia.
Experientia. 1975 Jun 15;31(6):669-71. doi: 10.1007/BF01944619.
Zotero 插件